Thromboelastography platelet mapping in healthy dogs using 1 analyzer versus 2 analyzers

The objective of this study was to describe the results of thromboelastography platelet mapping (TEG-PM) carried out using 2 techniques in 20 healthy dogs. Maximum amplitudes (MA) generated by thrombin (MA_thrombin), fibrin (MA_fibrin), adenosine diphosphate (ADP) receptor activity (MA_ADP), and thromboxane A₂ (TxA₂) receptor activity (stimulated by arachidonic acid, MA_AA) were recorded. Thromboelastography platelet mapping was carried out according to the manufacturer’s guidelines (2-analyzer technique) and using a variation of this method employing only 1 analyzer (1-analyzer technique) on 2 separate blood samples obtained from each dog. Mean ± standard deviation (SD)] MA values for the 1-analyzer/2-analyzer techniques were: MA_thrombin = 51.9 mm (± 7.1)/52.5 mm (± 8.0); MA_fibrin = 20.7 mm (± 21.8)/23.0 mm (± 26.1); MA_ADP = 44.5 mm (± 15.6)/45.6 mm (± 17.0); and MA_AA = 45.7 mm (± 11.6)/45.0 mm (± 15.4). Mean (± SD) percentage aggregation due to ADP receptor activity was 70.4% (± 32.8)/67.6% (± 33.7). Mean percentage aggregation due to TxA₂ receptor activity was 77.3% (± 31.6)/78.1% (± 50.2). Results of TEG-PM were not significantly different for the 1-analyzer and 2-analyzer methods. High correlation was found between the 2 methods for MA_fibrin concordance correlation coefficient (r) = 0.930]; moderate correlation was found for MA_thrombin (r = 0.70) and MA_ADP (r = 0.57); correlation between the 2 methods for MA_AA was lower (r = 0.32). Thromboelastography platelet mapping (TEG-PM) should be further investigated to determine if it is a suitable method for measuring platelet dysfunction in dogs with thrombopathy.